Clinical trial
A Randomized, Double-Blind Study to Compare the Efficacy of Treatment With…
NCT00330460 · Amgen, Industry · Completed
Key facts
| NCT number | NCT00330460 |
|---|---|
| Title | A Randomized, Double-Blind Study to Compare the Efficacy of Treatment With Denosumab Versus Alendronate Sodium in Postmenopausal Women With Low Bone Mineral Density. |
| Official title | A Randomized, Double-Blind Study to Compare the Efficacy of Treatment With Denosumab Versus Alendronate Sodium in Postmenopausal Women With Low Bone Mineral Denisty |
| Lead sponsor | Amgen, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Osteoporosis, Osteopenia |
| Intervention type | Drug |
| Interventions | Alendronate, Denosumab |
| Enrollment | 1,189 |
| Start date | May 1, 2006 |
| Primary completion | Nov 1, 2007 |
| Completion | Jan 1, 2008 |
| First posted | May 26, 2006 |
| Last update posted | Jan 24, 2011 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: